1. Home
  2. CTKB vs IFN Comparison

CTKB vs IFN Comparison

Compare CTKB & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • IFN
  • Stock Information
  • Founded
  • CTKB 1990
  • IFN 1993
  • Country
  • CTKB United States
  • IFN Singapore
  • Employees
  • CTKB N/A
  • IFN N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • IFN Finance/Investors Services
  • Sector
  • CTKB Health Care
  • IFN Finance
  • Exchange
  • CTKB Nasdaq
  • IFN Nasdaq
  • Market Cap
  • CTKB 450.9M
  • IFN 636.0M
  • IPO Year
  • CTKB 2021
  • IFN N/A
  • Fundamental
  • Price
  • CTKB $3.45
  • IFN $16.02
  • Analyst Decision
  • CTKB Hold
  • IFN
  • Analyst Count
  • CTKB 4
  • IFN 0
  • Target Price
  • CTKB $6.00
  • IFN N/A
  • AVG Volume (30 Days)
  • CTKB 1.2M
  • IFN 135.2K
  • Earning Date
  • CTKB 08-05-2025
  • IFN 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • IFN 8.68%
  • EPS Growth
  • CTKB N/A
  • IFN N/A
  • EPS
  • CTKB N/A
  • IFN N/A
  • Revenue
  • CTKB $197,050,000.00
  • IFN N/A
  • Revenue This Year
  • CTKB $0.91
  • IFN N/A
  • Revenue Next Year
  • CTKB $7.75
  • IFN N/A
  • P/E Ratio
  • CTKB N/A
  • IFN N/A
  • Revenue Growth
  • CTKB N/A
  • IFN N/A
  • 52 Week Low
  • CTKB $2.37
  • IFN $14.40
  • 52 Week High
  • CTKB $7.63
  • IFN $21.25
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 52.53
  • IFN 41.61
  • Support Level
  • CTKB $3.26
  • IFN $16.38
  • Resistance Level
  • CTKB $3.63
  • IFN $16.60
  • Average True Range (ATR)
  • CTKB 0.22
  • IFN 0.17
  • MACD
  • CTKB 0.01
  • IFN -0.04
  • Stochastic Oscillator
  • CTKB 59.78
  • IFN 19.44

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About IFN India Fund Inc. (The)

India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing primarily in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others. Geographically, all the business activity functions through the market of the United States.

Share on Social Networks: